Cerlapirdine

From WikiMD's WELLNESSPEDIA


Overview[edit]

Cerlapirdine is a pharmaceutical drug that was investigated for its potential use in the treatment of cognitive disorders, particularly those associated with Alzheimer's disease. It is classified as a selective serotonin receptor antagonist, specifically targeting the 5-HT6 receptor.

Mechanism of Action[edit]

Cerlapirdine functions by selectively inhibiting the 5-HT6 receptor, a subtype of the serotonin receptor that is predominantly found in the central nervous system. The blockade of this receptor is believed to enhance the release of acetylcholine and other neurotransmitters, which are crucial for cognitive function. This mechanism suggests potential benefits in improving memory and learning in patients with cognitive impairments.

Development and Research[edit]

Cerlapirdine was developed as part of a broader effort to find effective treatments for neurodegenerative diseases. Initial studies focused on its ability to improve cognitive deficits in preclinical models. However, despite promising early results, further clinical trials were necessary to establish its efficacy and safety in humans.

Clinical Trials[edit]

Clinical trials for cerlapirdine aimed to assess its impact on cognitive function in patients with Alzheimer's disease. These trials were designed to evaluate both the safety profile and the therapeutic potential of the drug. Unfortunately, the outcomes of these trials did not demonstrate significant improvements over existing treatments, leading to a halt in its development.

Chemical Structure[edit]

Chemical structure of cerlapirdine

Cerlapirdine is characterized by its unique chemical structure, which allows it to selectively bind to the 5-HT6 receptor. The molecular design was optimized to enhance its specificity and minimize off-target effects.

Potential Applications[edit]

While cerlapirdine did not advance to become a marketed drug, the research surrounding its development contributed valuable insights into the role of 5-HT6 receptors in cognitive processes. This knowledge continues to inform ongoing research in the field of neuropharmacology.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Cerlapirdine&oldid=6292224"